Sort
10,766 grants matching “checkpoint inhibitor”
Designer Probiotics for the treatment of intestinal infection and inflammation
$744,110Cammie Lesser · Massachusetts General Hospital · R01 · FY2017 · DK
Applications of a robust, vector-free intracellular delivery platform for immune cells
$743,988Scott McNabb Loughhead · Sqz Biotechnologies Company, Inc. · R44 · FY2017 · GM
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2024 · CA
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2025 · CA
Evaluation of Novel Radiation Modifiers
$742,307Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Augmented Transgenic TCR-mediated tumor therapy
$742,305Aude Chapuis · University Of Washington · P01 · FY2025 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$742,035Andrea Hope Bild · Beckman Research Institute/City Of Hope · U01 · FY2022 · CA
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
$741,917Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$741,840David P Carbone · Ohio State University · R01 · FY2025 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$741,049Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Administrative Core
$741,000Jun Yan · University Of Louisville · P20 · FY2020 · GM
PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments
$740,955Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2024 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$740,152Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments
$739,484Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2025 · CA
Project 1 - Clinical Trial
$738,729Andrew R Haas · University Of Pennsylvania · P01 · FY2019 · CA
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$737,882Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Administrative Core
$737,703Jun Yan · University Of Louisville · P20 · FY2021 · GM
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$737,672Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$737,672Adam Mor · Columbia University Health Sciences · R01 · FY2024 · AI
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$737,605Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2018 · CA
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors
$737,531Michael Karin · University Of California, San Diego · U01 · FY2018 · AA
Identifying new immunotherapeutic targets for endocrine autoimmunity.
$737,346Maureen A Su · University Of California Los Angeles · U19 · FY2024 · AI
Identifying new immunotherapeutic targets for endocrine autoimmunity.
$737,346Maureen A Su · University Of California Los Angeles · U19 · FY2025 · AI
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$736,864Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Evolution of gliomas during treatment and resistance
$736,601Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2021 · CA